Tensilon

Active Ingredient(s): Edrophonium
FDA Approved: * May 3, 1951
Pharm Company: * VALEANT PHARM INTL
Category: Myasthenic Syndrome

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Tensilon Overview

Edrophonium is a readily reversible acetylcholinesterase inhibitor. It prevents breakdown of the neurotransmitter acetylcholine and acts by competitively inhibiting the enzyme acetylcholinesterase, mainly at the neuromuscular junction. It is sold under the trade names Tensilon and Enlon (according to FDA Orange Book). Contents 1 Clinical uses 2 Chemistry 3 Pharmacokinetics 4 References 5 Further reading Clinical uses Edrophonium (by the so-called Tensilon test) is used to differentiate...

Read more Tensilon Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Edrophonium

Recent Tensilon Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Other drugs which contain Edrophonium or a similar ingredient: (5 results)

• EDROPHONIUM
• ENLON Edrophonium
• REVERSOL Edrophonium
• ATROPINE + EDROPHONIUM
• ENLON PLUS Atropine + Edrophonium

Related Tensilon Topics: